Skip to main content

Advertisement

Log in

Palliative care for end-stage heart failure

  • Published:
Current Heart Failure Reports Aims and scope Submit manuscript

Abstract

Heart failure is growing in prevalence. Despite an array of treatments targeting a complicated pathophysiology, heart failure ultimately leads to death, and thus there is a clear need to provide palliative care to persons with end-stage heart failure. Palliative care, or education and support of the patient and family and management of distressing symptoms, should be provided throughout the course of the illness. Clinicians need additional information about how to palliate symptoms in advanced heart failure. This article summarizes recent reports about prognostication and identification of patients who are likely to die soon, and the management of fatigue, dyspnea, pain, and depression in heart failure. Palliative care or supportive care of the patient and family should be incorporated into comprehensive care throughout the course of heart failure. Data about hospice care for persons with heart failure are summarized.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Adams KF, Zammad F, France N: Clinical definition and epidemiology of advanced heart failure. Am Heart J 1998, 135:S204-S215.

    Article  PubMed  Google Scholar 

  2. Heiat A, Gross CP, Krumholz HM: Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 2002, 162:1682–1688.

    Article  PubMed  Google Scholar 

  3. Stewart S, McMurray JV: Palliative care for heart failure: time to move beyond treating and curing to improving the end of life. BMJ 2002, 325:915–916.

    Article  PubMed  Google Scholar 

  4. Hunt SA, Baker DW, Chin MH, et al.: American College of Cardiology/ American Heart Association guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. J Amer Coll Cardiol 2001, 38:2101–2113.

    Article  CAS  Google Scholar 

  5. Hauptman PJ, Havranek E: Choosing the heart failure patient appropriate for palliative care. Arch Int Med 2005, 165:374–378. The authors suggest an algorithm to follow in choosing a palliative approach to HF patients.

    Article  Google Scholar 

  6. Ezekowitz JA, McAlister FA, Armstrong PW: Anemia is common in heart failure and is associated with poor outcomes. Insights from a cohort of 12,065 patients with new-onset heart failure. Circulation 2003, 107:223–225.

    Article  PubMed  Google Scholar 

  7. Forman DE, Butler J, Wang Y, et al.: Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 2004, 43:61–67.

    Article  PubMed  Google Scholar 

  8. Anker SD, Negassa A, Coats AJ, et al.: Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 2003, 361:1077–1083.

    Article  PubMed  CAS  Google Scholar 

  9. Gustafsson F, Torp-Pedersen C, Seibaek M, et al.: Effect of age on short and long-term mortality in patients admitted to hospital with congestive heart failure. European Heart J 2004, 25:1711–1717.

    Article  Google Scholar 

  10. Sullivan MD, Levy WC, Crane BA, et al.: Usefulness of depression to predict time to combined end point of transplant or death for outpatients with advanced heart failure. Am J Cardiol 2004, 94:1577–1580.

    Article  PubMed  Google Scholar 

  11. de Denus S, Spinler SA, Jessup M, Kao A: History of depression as a predictor of adverse outcomes in patients hospitalized for decompensated heart failure. Pharmacotherapy 2004, 24:1306–1310.

    Article  PubMed  Google Scholar 

  12. Hershberger RE, Nauman D, Walker TL, et al.: Care processes and clinical outcomes of Continuous Outpatient Support with Inotropes (COSI) in patients with refractory endstage heart failure. J Card Fail 2003, 9:180–187.

    Article  PubMed  Google Scholar 

  13. Stevenson LW, Miller LW, Desvigne-Nickens P, et al.: Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Circulation 2004, 110:975–981.

    Article  PubMed  Google Scholar 

  14. Kittleson M, Hurwitz S, Shah MR, et al.: Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality. J Am Coll Cardiol 2003, 41:2029–2035.

    Article  PubMed  CAS  Google Scholar 

  15. Parissis JT, Adamopoulos S, Rigas A: Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. Am J Cardiol 2004, 94:1326–1328.

    Article  PubMed  CAS  Google Scholar 

  16. Havranek EP, Spretus JA, Masoudi FA, et al.: Predictors of the onset of depressive symptoms in patients with heart failure. J Am Coll Cardiol 2004, 44:2333–2338.

    Article  PubMed  Google Scholar 

  17. Lee DS, Austin PC, Rouleau JL, et al.: Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 2003, 290:2582–2587. This manuscript presents scales based on easily obtained clinical variables to assess mortality risk for 30 days or 1 year.

    Google Scholar 

  18. Felker GM, Leimberger JD, Califf RM, et al.: Risk stratification after hospitalization for decompensated heart failure. J Card Fail 2004, 10:460–466.

    Article  PubMed  Google Scholar 

  19. Fonarow GC, Adams KF Jr, Abraham WT, et al., for the ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 2005, 293:572–580.

    Article  PubMed  CAS  Google Scholar 

  20. World Health Organization: WHO definition of palliative care. www.who.int/cancer/palliative/definition/en/. Accessed July 13, 2005.

  21. National Consensus Project For Quality Palliative Care: Guidelines for Quality Palliative Care 2004. www.nationalconsensusproject. org/Guideline.pdf. Accessed July 13, 2005. These are well-organized guidelines that identify the optimal components of interdisciplinary palliative care.

  22. Baker DW, Brown J, Chan KS, et al.: A telephone survey to measure communication, education, self-management, and health status for patients with heart failure: the Improving Chronic Illness Care Evaluation (ICICE). J Card Fail 2005, 11:36–42.

    Article  PubMed  Google Scholar 

  23. Fried TR, Bradley EH, O’Leary J: Prognosis communication in serious illness: perceptions of older patients, caregivers, and clinicians. J Am Geriatr Soc 2003, 51:1398–1403.

    Article  PubMed  Google Scholar 

  24. Epstein RM, Alper BS, Quill TE: Communicating evidence for participatory decision making. JAMA 2004, 291:2359–2366.

    Article  PubMed  CAS  Google Scholar 

  25. Quill TE: Initiating end-of-life discussions with seriously ill patients: addressing the "elephant in the room". JAMA 2000, 284:2502–2507.

    Article  PubMed  CAS  Google Scholar 

  26. DeWalt DA, Pignone M, Malone R, et al.: Development and pilot testing of a disease management program for low literacy patients with heart failure. Patient Ed and Counsel 2004, 55:78–86.

    Article  Google Scholar 

  27. Goodlin SJ, Hauptman PJ, Arnold R, et al.: Consensus statement: palliative and supportive care in advanced heart failure [review]. J Card Fail 2004, 10:200–209. This article reviews current knowledge and identifies gaps and needed research in palliative care for advanced heart failure.

    Article  PubMed  Google Scholar 

  28. Dracup K, Walden JA, Stevenson LW, Brecht M: Quality of life with advanced heart failure. J Heart Lung Transplant 1992, 11:273–279.

    PubMed  CAS  Google Scholar 

  29. Krum H, Gilbert RE: Demographics and concomitant disorders in heart failure. Lancet 2003, 362:147–158.

    Article  PubMed  Google Scholar 

  30. Walke LM, Gallo WT, Tinetti ME, Fried TR: The burden of symptoms among community-dwelling older persons with advanced chronic disease. Arch Intern Med 2004, 164:2321–2324.

    Article  PubMed  Google Scholar 

  31. Nordgren L, Sorensen S: Symptoms experienced in the last six months of life in patients with end-stage heart failure. Eur J Cardiovasc Nurs 2003, 2:213–217.

    Article  PubMed  Google Scholar 

  32. Gwandry-Sridhar FH, Flintoft V, Lee DS, et al.: A systematic review and meta-analysis of studies comparing readmission rates and mortality rates in patients with heart failure. Arch Intern Med 2004, 164:2315–2320.

    Article  Google Scholar 

  33. Bristow MR, Saxon LA, Boehmer J, et al.: Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004, 105:1453–1458.

    Google Scholar 

  34. Cleland JGF, Daubert JC, Erdmann E, et al.: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005, 352–363.

  35. Sullivan MD, Newton K, Hecht J, et al.: Depression and health status in elderly patients with heart failure: a 6-month prospective study in primary care. Am J Geriatr Cardiol 2004, 13:252–260.

    Article  PubMed  Google Scholar 

  36. Mancini DM, Katz SD, Lang CC, et al.: Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 2003, 107:294–299.

    Article  PubMed  CAS  Google Scholar 

  37. Colin Ramirez E, Castillo Martinez L, Orea Tejeda A, et al.: Effects of a nutritional intervention on body composition, clinical status and quality of life in patients with heart failure. Nutrition 2004, 20:890–895.

    Article  PubMed  Google Scholar 

  38. Köhnlein T, Welte T, Tan LB, Elliott MW: Central sleep apnoea syndrome in patients with chronic heart disease: a critical review of the current literature. Thorax 2002, 57:547–554.

    Article  PubMed  Google Scholar 

  39. Kaneko Y, Floras JS, Usui K, et al.: Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003, 348:1233–1241.

    Article  PubMed  Google Scholar 

  40. Naughton MT, Benard DC, Liu PP, et al.: Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 1995, 152:473–479.

    PubMed  CAS  Google Scholar 

  41. Mansfield DR, Gollogly NC, Kaye DM, et al.: Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004, 169:361–366.

    Article  PubMed  Google Scholar 

  42. Beniaminovitz A, Lang CC, LaManca J, Mancini DM: Selective low-level leg muscle training alleviates dyspnea in patients with heart failure. J Am Coll Cardiol 2002, 40:1602–1608.

    Article  PubMed  Google Scholar 

  43. Belardinelli R, Georgiou D, Cianci G, et al.: Randomized controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life and clinical outcome. Circulation 1999, 99:1173–1182.

    PubMed  CAS  Google Scholar 

  44. Conraads VM, Beckers P, Vaes J, et al.: Combined endurance/ resistance training reduces NT-proBNP levels in patients with chronic heart failure. Eur Heart J 2004, 25:1797–1805.

    Article  PubMed  CAS  Google Scholar 

  45. Yeh GY, Wood MJ, Lorell BH, et al.: Effects of tai chi mindbody movement therapy on functional status and exercise capacity in patients with chronic heart failure: a randomized controlled trial. Am J Med 2004, 117:541–548.

    Article  PubMed  Google Scholar 

  46. King ML, Dracup KA, Fonarow GC, Woo MA: Isotonic exercise using handheld weights in patients with heart failure. J Heart Lung Transplant 2000, 19:1209–1218.

    Article  PubMed  CAS  Google Scholar 

  47. Smart N, Marwick TH: Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity. Am J Med 2004, 116:693–706.

    Article  PubMed  Google Scholar 

  48. Weber KT: Furosemide in the long-term management of heart failure. The good, the bad and the uncertain. J Am Coll Cardiol 2004, 44:1308–1310.

    PubMed  CAS  Google Scholar 

  49. Bitar F, Akhter M, Khan S, et al.: Survey of the use of organic nitrates for the treatment of chronic congestive heart failure in the United States. Am J Cardiol 2004, 94:1465–1468.

    Article  PubMed  CAS  Google Scholar 

  50. Colucci WS, Elkayam U, Horton DP, et al.: Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med 2000, 343:246–253.

    Article  PubMed  CAS  Google Scholar 

  51. Chen HH, Redfield MM, Nordstrom LJ, et al.: Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure. J Card Fail 2004, 10:115–119.

    Article  PubMed  CAS  Google Scholar 

  52. Booth S, Wade R, Johnson M, et al.: The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine. Respir Med 2004, 98:66–77.

    Article  PubMed  Google Scholar 

  53. Goodlin SJ, Kutner JS, Connor SR, et al.: Hospice care for heart failure patients. J Pain Symptom Manage 2005, 29:525–528.

    Article  PubMed  Google Scholar 

  54. Johnson MJ: Morphine for the relief of breathlessness in patients with chronic heart failure. Eur Heart J 2002, 4:753–756.

    Article  CAS  Google Scholar 

  55. Chua TP, Harrington D, Ponikowski P, et al.: Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 1997, 29:147–152.

    Article  PubMed  CAS  Google Scholar 

  56. Williams SG, Wright DJ, Marshall P, et al.: Safety and potential benefits of low dose diamorphine during exercise in patients with chronic heart failure. Heart 2003, 89:1085–1086.

    Article  PubMed  CAS  Google Scholar 

  57. Levenson JW, McCarthy EP, Lynn J, et al.: The last six months of life for patients with congestive heart failure. J Am Geriatr Soc 2000, 48:S101-S109.

    PubMed  CAS  Google Scholar 

  58. Jaagosild P, Dawson NV, Thomas C, et al. for the SUPPORT Investigators. Outcomes of acute exacerbation of severe congestive heart failure, quality of life, resource use and survival. Arch Intern Med 1998, 158:1081–1089.

    Article  PubMed  CAS  Google Scholar 

  59. Weiss SC, Emanuel LL, Fairclough DL, Emanuel EJ: Understanding the experience of pain in terminally ill patients. Lancet 2001, 357:1311–1315.

    Article  PubMed  CAS  Google Scholar 

  60. Walke LM, Gallo WT, Tinetti ME, Fried TR: The burden of symptoms among community-dwelling older persons with advanced chronic disease. Arch Intern Med 2004, 164:2321–2324.

    Article  PubMed  Google Scholar 

  61. Weir MR: Renal effects of nonselective NSAIDs and coxibs. Cleve Clin J Med 2002, 69:SI53–58.

    Article  PubMed  Google Scholar 

  62. Page J, Henry D: Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med 2000, 160:777–784.

    Article  PubMed  CAS  Google Scholar 

  63. Heerdink E, Leufkens H, Herings R, et al.: NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med 1998, 158:1108–1112.

    Article  PubMed  CAS  Google Scholar 

  64. Mamdani M, Juurlink DN, Lee DS, et al.: Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study. Lancet 2004, 363:1751–1756.

    Article  PubMed  CAS  Google Scholar 

  65. Goldberg SH, Von Feldt JM, Lonner JH: Pharmacologic therapy for osteoarthritis. Am J Orthop 2002, 31:673–680.

    PubMed  Google Scholar 

  66. Horne G, Payne S: Removing the boundaries: palliative care for patients with heart failure. Palliat Med 2004, 18:291–296.

    Article  PubMed  Google Scholar 

  67. Doering LV, Dracup K, Caldwell MA, et al.: Is coping style linked to emotional states in heart failure patients? J Card Fail 2004, 10:344–349.

    Article  PubMed  Google Scholar 

  68. Carels RA: The association between disease severity, functional status, depression and daily quality of life in congestive heart failure patients. Qual of Life Res 2004, 13:63–72.

    Article  Google Scholar 

  69. Gesell SB, Clark PA, Williams A: Inpatient heart failure treatment from the patient’s perspective. Qual Manag Health Care 2004, 13:154–165.

    PubMed  Google Scholar 

  70. Murray SA, Kendall M, Boyd K, et al.: Exploring the spiritual needs of people dying of lung cancer or heart failure: a prospective qualitative interview study of patients and their carers. Palliat Med 2004, 18:39–45.

    Article  PubMed  Google Scholar 

  71. Sullivan M, Levy WC, Russo JE, Spertus JA: Depression and health status in patients with advanced heart failure: a prospective study in tertiary care. J Card Fail 2004, 10:390–396.

    Article  PubMed  Google Scholar 

  72. Breitbart W, Rosenfeld B, Kaim M, Funesti-Esch J: A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease. Arch Intern Med 2001, 161:411–420.

    Article  PubMed  CAS  Google Scholar 

  73. Sugawara Y, Akechi T, Shima Y, et al.: Efficacy of methylphenidate for fatigue in advanced cancer patients: a preliminary study. Palliat Med 2002, 16:261–263.

    Article  PubMed  Google Scholar 

  74. Kirby D, Ames D: Selective serotonin reuptake inhibitors and hyponatremia. J Geriatr Psych 2001, 16:484–493.

    Article  CAS  Google Scholar 

  75. Stuart B, Alexander C, Arenella C, et al. for Standards and Accreditation Committee, Medical Guidelines Task Force: Medical guidelines for determining prognosis in selected non-cancer diseases. Arlington, VA: National Hospice Organization; 1996.

    Google Scholar 

  76. National Hospice and Palliative Care Organization. Hospice Facts and Figures. http://www.nhpco.org/files/public/ Hospice_Facts_110104.pdf. Accessed July 15, 2005.

  77. Lopez-Candales A, Carron C, Schwartz J: Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes. Clin Cardiol 2004, 27:23–28.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goodlin, S.J. Palliative care for end-stage heart failure. Curr Heart Fail Rep 2, 155–160 (2005). https://doi.org/10.1007/s11897-005-0024-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11897-005-0024-0

Keywords

Navigation